Delaware Court Upholds Poison Pill With 'Grandfather' Exemption for Existing Large Stockholder

03 September 2010 Publication
Authors: Gardner F. Davis Danielle R. Whitley

Delaware Corporate, Westlaw Journal/Thomson Reuters

Foley Partner Gardner Davis and Senior Counsel Danielle Whitley authored an article that appeared in Delaware Corporate, Westlaw Journal/Thomson Reuters on September 3, 2010 titled "Delaware Court Upholds Poison Pill With ‘Grandfather' Exemption for Existing Large Stockholder." The authors discuss the Delaware Chancery Court’s decision to uphold a shareholder rights plan, or "poison pill," employed by Barnes & Noble to stop a dissident shareholder’s rapid accumulation of stock. Focusing on the court’s approval of a "grandfather" exemption that allowed a major shareholder to exceed the pill’s 20 percent limit but capped the investor’s holding at that level, the authors note that Barnes & Noble’s board was entitled to take reasonable and non-preclusive action to ensure that an activist investor was unable to seek control block advantages at the expense of other investors.

Related Services

Insights

Cryptocurrency in China is like BIG BROTHER in 1984!
20 October 2019
Internet, IT & e-Discovery Blog
California Governor Signs New Telehealth Insurance Law
18 October 2019
Health Care Law Today
Continued Increase in E-Commerce and Online Ordering Changes Landscape of Urban Transportation
17 October 2019
Dashboard Insights
CMS Proposes Revisions to Stark Law
16 October 2019
Health Care Law Today
PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.